Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Silo Pharma (SILO) Other Non Operating Income (2020 - 2024)

Silo Pharma (SILO) has disclosed Other Non Operating Income for 4 consecutive years, with -$2618.0 as the latest value for Q3 2024.

  • Quarterly Other Non Operating Income changed N/A to -$2618.0 in Q3 2024 from the year-ago period, while the trailing twelve-month figure was -$14242.0 through Dec 2024, changed N/A year-over-year, with the annual reading at -$14242.0 for FY2024, N/A changed from the prior year.
  • Other Non Operating Income hit -$2618.0 in Q3 2024 for Silo Pharma, up from -$2929.0 in the prior quarter.
  • In the past five years, Other Non Operating Income ranged from a high of $97471.0 in Q3 2021 to a low of -$198000.0 in Q2 2020.
  • Historically, Other Non Operating Income has averaged $3134.5 across 4 years, with a median of $84.0 in 2022.
  • Biggest five-year swings in Other Non Operating Income: skyrocketed 109.64% in 2021 and later tumbled 101.48% in 2022.
  • Year by year, Other Non Operating Income stood at $318.0 in 2020, then surged by 30551.26% to $97471.0 in 2021, then crashed by 100.29% to -$283.0 in 2022, then plummeted by 825.09% to -$2618.0 in 2024.
  • Business Quant data shows Other Non Operating Income for SILO at -$2618.0 in Q3 2024, -$2929.0 in Q2 2024, and -$8695.0 in Q1 2024.